274 related articles for article (PubMed ID: 9498700)
21. Modulation of multidrug resistance in multiple myeloma.
Sonneveld P
Baillieres Clin Haematol; 1995 Dec; 8(4):831-44. PubMed ID: 8845575
[TBL] [Abstract][Full Text] [Related]
22. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
23. Preliminary immunocytochemical studies of MDR-1 and MDR-3 Pgp expression in B-cell leukaemias.
Larkin A; Moran E; Alexander D; Clynes M
Adv Exp Med Biol; 1999; 457():65-70. PubMed ID: 10500781
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of P-glycoprotein expression in haematological malignancies.
Nooter K; Sonneveld P
Leuk Res; 1994 Apr; 18(4):233-43. PubMed ID: 7909572
[TBL] [Abstract][Full Text] [Related]
25. Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay.
Kang YK; Zhan Z; Regis J; Alvarez M; Robey R; Meadows B; Dickstein B; Lee JS; Otsuki T; Stetler-Stevenson M
Blood; 1995 Aug; 86(4):1515-24. PubMed ID: 7632959
[TBL] [Abstract][Full Text] [Related]
26. P-glycoprotein-mediated colchicine resistance in different cell lines correlates with the effects of colchicine on P-glycoprotein conformation.
Druley TE; Stein WD; Ruth A; Roninson IB
Biochemistry; 2001 Apr; 40(14):4323-31. PubMed ID: 11284688
[TBL] [Abstract][Full Text] [Related]
27. Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein.
Ruth A; Stein WD; Rose E; Roninson IB
Biochemistry; 2001 Apr; 40(14):4332-9. PubMed ID: 11284689
[TBL] [Abstract][Full Text] [Related]
28. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study.
Larkin A; O'Driscoll L; Kennedy S; Purcell R; Moran E; Crown J; Parkinson M; Clynes M
Int J Cancer; 2004 Nov; 112(2):286-94. PubMed ID: 15352042
[TBL] [Abstract][Full Text] [Related]
29. Roles of multidrug resistance genes in breast cancer chemoresistance.
Kuo MT
Adv Exp Med Biol; 2007; 608():23-30. PubMed ID: 17993230
[TBL] [Abstract][Full Text] [Related]
30. Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.
Coley HM; Verrill MW; Gregson SE; Odell DE; Fisher C; Judson IR
Eur J Cancer; 2000 May; 36(7):881-8. PubMed ID: 10785593
[TBL] [Abstract][Full Text] [Related]
31. Aberrant transcription from an unrelated promoter can result in MDR-1 expression following drug selection in vitro and in relapsed lymphoma samples.
Huff LM; Wang Z; Iglesias A; Fojo T; Lee JS
Cancer Res; 2005 Dec; 65(24):11694-703. PubMed ID: 16357181
[TBL] [Abstract][Full Text] [Related]
32. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance.
Lee JJ; Hughes CS; Fine RL; Page RL
Cancer; 1996 May; 77(9):1892-8. PubMed ID: 8646690
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressors as multidrug resistance reversal agents.
Morjani H; Madoulet C
Methods Mol Biol; 2010; 596():433-46. PubMed ID: 19949935
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistance gene (MDR 1) expression in neuro-axial tumours of children and young adults.
Billson AL; Palmer JB; Walker DA; Lowe J
Br J Neurosurg; 1994; 8(5):585-91. PubMed ID: 7857540
[TBL] [Abstract][Full Text] [Related]
35. Dihydro-beta-agarofuran sesquiterpenes: a new class of reversal agents of the multidrug resistance phenotype mediated by P-glycoprotein in the protozoan parasite Leishmania.
Cortés-Selva F; Jiménez IA; Munoz-Martínez F; Campillo M; Bazzocchi IL; Pardo L; Ravelo AG; Castanys S; Gamarro F
Curr Pharm Des; 2005; 11(24):3125-39. PubMed ID: 16178749
[TBL] [Abstract][Full Text] [Related]
36. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O
J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein (Review).
Tian Y; Lei Y; Wang Y; Lai J; Wang J; Xia F
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37654171
[TBL] [Abstract][Full Text] [Related]
38. Targeting multidrug resistant tumor cells with a recombinant single-chain FV fragment directed to P-glycoprotein.
Niv R; Assaraf YG; Segal D; Pirak E; Reiter Y
Int J Cancer; 2001 Dec; 94(6):864-72. PubMed ID: 11745490
[TBL] [Abstract][Full Text] [Related]
39. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme.
Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P
Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420
[TBL] [Abstract][Full Text] [Related]
40. The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer.
Baker EK; El-Osta A
Exp Cell Res; 2003 Nov; 290(2):177-94. PubMed ID: 14567978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
